武田 利和

Medicine & Life Sciences

1. Prostatectomy 100%
2. Adrenalectomy 65%
3. Prostatic Neoplasms 62%
4. Recurrence 55%
5. Renal Cell Carcinoma 47%
6. Nephrectomy 45%
7. Urinary Bladder Neoplasms 39%
8. Neoplasms 36%
9. Operative Time 29%
10. Nephroureterectomy 28%
11. Prostate-Specific Antigen 28%
12. Pneumoperitoneum 28%
13. Carcinoma 27%
14. Prostate 24%
15. Neoplasm Metastasis 23%
16. Therapeutics 19%
17. Intra-Abdominal Fat 19%
18. Salvage Therapy 18%
19. Neoadjuvant Therapy 18%
20. Survival 17%
21. Surgeons 17%
22. C-Reactive Protein 17%
23. Pheochromocytoma 16%
24. Neoplasm Grading 15%
25. Androgens 14%
26. Urinary Bladder 14%
27. Biopsy 14%
28. Seminal Vesicles 14%
29. Radiotherapy 14%
30. Aldosterone 13%
31. Abdominal Obesity 13%
32. Fats 12%
33. Adenoma 12%
34. Magnetic Resonance Imaging 12%
35. Urethra 12%
36. Blood Proteins 12%
37. TachoSil 11%
38. Urachal cancer 11%
39. Appointments and Schedules 11%
40. Cohort Studies 10%
41. Laparoscopy 10%
42. dactolisib 10%
43. Adrenocortical Adenoma 10%
44. Catheters 10%
45. Umbilicus 10%
46. Lymphocele 9%
47. Kisspeptins 9%
48. Nephrotomy 8%
49. Drug Therapy 8%
50. Varicocele 8%